Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Julia SeegerJochen WöhrleBruno SchellerAhmed FarahMarc-Alexander OhlowNorman MangnerSven Möbius-WinklerDaniel WeilenmannGeorg StachelGregor LeibundgutPeter RickenbacherMarco CattaneoNicole GilgenChristoph KaiserRaban V Jegernull On Behalf Of The Basket-Small InvestigatorsPublished in: Journal of cardiovascular development and disease (2023)
DCB compared to DES for treatment of de novo coronary lesions in diabetic patients was associated with similar rates of MACE and numerically lower need for TVR both for ITDM and NITDM patients.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- newly diagnosed
- type diabetes
- end stage renal disease
- glycemic control
- phase iii
- ejection fraction
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- chronic kidney disease
- cardiovascular events
- antiplatelet therapy
- phase ii
- prognostic factors
- st elevation myocardial infarction
- open label
- study protocol
- peritoneal dialysis
- heart failure
- randomized controlled trial
- emergency department
- electronic health record
- replacement therapy